Results 111 to 120 of about 12,754 (165)

Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study. [PDF]

open access: yesBreast Cancer Res Treat
Tolosa P   +25 more
europepmc   +1 more source

Changing Policy Narratives in Addressing Indonesia's Deforestation

open access: yesReview of Policy Research, Volume 43, Issue 2, March 2026.
ABSTRACT Indonesia's forests stand at the crossroads of economic prosperity and ecological preservation, where the demand for timber and palm oil clashes with the urgent need to protect biodiversity and mitigate climate change. The dual role of Indonesia's forests has led to decades of policy tension, primarily contesting their function as engines of ...
Hafidz Wibisono   +7 more
wiley   +1 more source

[Dual Test in Pregnant Women: Case of a General Zone Hospital with Family Medicine]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Reyes-Berlanga ML   +2 more
europepmc   +1 more source

Incisional Hernia Development: Wound Healing Gone Wrong?

open access: yesWound Repair and Regeneration, Volume 34, Issue 2, March/April 2026.
ABSTRACT Incisional hernia (IH) is a common complication of abdominal surgeries, characterised by the protrusion of abdominal contents through a weakened surgical scar. Despite advancements in surgical techniques and biomaterials, IH remains a significant clinical and economic burden, with recurrence rates reaching up to 32% after repair.
Asim A. Abbas   +3 more
wiley   +1 more source

[A pioneering article that opens new lines of research into patient experience with clinical ultrasound]. [PDF]

open access: yesAten Primaria
Fernández-Guerrero IM   +2 more
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

open access: yesBiomedica
Panesso GA   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy